
22 Jul Angiocrine Bioscience
Paul Finnegan, M.D., CEO
Oct. 12 | 1:30pm | BlueRock Therapeutics Ballroom
San Diego, CA
(Private)
In-person Presentation
Angiocrine Bioscience aims to transform medicine by harnessing the natural powers of endothelial cells to enable the repair of tissues and organs for patients with life-threatening and debilitating conditions through its proprietary, genetically engineered, E-CEL technology platform.
www.angiocrinebioscience.com